Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Baylor Collaborate on Customized CGH Microarrays

NEW YORK (GenomeWeb News) – Agilent Technologies today said that it is collaborating with Baylor College of Medicine's Medical Genetics Laboratories to provide customized comparative genomics hybridization microarrays to researchers.

Baylor has designed six new microarrays that combined with Agilent's microarray manufacturing capabilities will "enable advanced discoveries in cancer and cytogenetics research," Agilent said.

"Originally focused on microdeletions and microduplications, our current designs have been continually improved over the past 10 years and are now highly robust, with the ability to detect exon-level deletions and duplications," Brandon Perthuis, director of business development at the BCM Medical Genetic Laboratories, said in a statement. "Our exon array targets approximately 1,700 genes and includes probes used for SNP analysis for the detection" of absence of heterozygosity and uniparental disomy.

Financial and other terms of the deal were not disclosed.